The landscape of dementia analysis has developed drastically with the appearance of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments that could detect Alzheimer's pathology years just before signs or symptoms arise. Whilst these technological improvements characterize remarkable progress in kno